AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus

(2014) W.D. Strain et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Diagnosis and Classification of Diabetes Mellitus

(2013)   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial

(2011) P. Raskin et al.   DIABETES OBESITY & METABOLISM

Patient-Reported Outcomes in Adults with Type 2 Diabetes Using Mealtime Inhaled Technosphere Insulin and Basal Insulin Versus Premixed Insulin

(2011) Mark Peyrot et al.   Diabetes Technology & Therapeutics

Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration

(2011) James P. Cassidy et al.   PHARMACEUTICAL RESEARCH

Barriers to Insulin Initiation: The Translating Research Into Action for Diabetes Insulin Starts Project

(2010) A. J. Karter et al.   DIABETES CARE

Effect of Technosphere Inhaled Insulin on Quality of Life and Treatment Satisfaction

(2010) Mark Peyrot et al.   Diabetes Technology & Therapeutics

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

(2010) Julio Rosenstock et al.   LANCET

Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin

(2009) K. Rave et al.   DIABETES OBESITY & METABOLISM

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

(2008) J. Rosenstock et al.   DIABETES CARE